DR. JOHN FRANCIS FERGUSON M.D. NPI 1841245560

NPI Information

  • NPI: 1841245560
  • Provider Name: DR. JOHN FRANCIS FERGUSON, M.D.
  • Classification: Internal Medicine - 207RP1001X
  • Specialization: Pulmonary Disease
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 111 MALTESE DR
    MIDDLETOWN, NY
    ZIP 10940
  • Phone: (845) 342-4774

Map and Directions

Get Directions

NPI Details

DR. John Francis Ferguson, M.D. is a pulmonary disease internal medicine in Middletown, NY with 39 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. DR. John Francis Ferguson, M.D. NPI is 1841245560. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY CENTRAL DEL CARIBE ESCUELA DE MEDICINA
Graduation Year:1987

The provider's business location address is:

111 MALTESE DR
MIDDLETOWN, NY
ZIP 10940-115
Phone: (845) 342-4774
Fax: (845) 818-7555

The NPI 1841245560 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, omalizumab, 5 mg (HCPCS:J2357)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Hemoglobin a1c level (HCPCS:83036)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Uric acid level, blood (HCPCS:84550)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Thyroid hormone evaluation (HCPCS:84479)
  • Vitamin d-3 level (HCPCS:82306)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Test to determine lung volumes using sensors (HCPCS:94726)
  • Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
  • Test to examine how well the lungs exchange gases (HCPCS:94729)
  • Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
  • Urinalysis, manual test (HCPCS:81002)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Magnesium level (HCPCS:83735)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Phosphate level (HCPCS:84100)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Test to measure the level of nitric oxide gas (HCPCS:95012)
  • Ferritin (blood protein) level (HCPCS:82728)
  • X-ray of chest, 2 views (HCPCS:71046)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
  • Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
  • Screening 3d breast mammography (HCPCS:77063)
  • Screening mammography (HCPCS:77067)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Administration of vaccine (HCPCS:90471)
  • Advance care planning, first 30 minutes (HCPCS:99497)
  • Transitional care management services for problem of high complexity (HCPCS:99496)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Mri scan of lower spinal canal without contrast (HCPCS:72148)
  • Transitional care management services for problem of moderate complexity (HCPCS:99495)

The enumeration date for this NPI number is 5/23/2006 and was last updated on 1/24/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine177820NEW YORKNo
2207RC0200XInternal MedicineCritical Care Medicine177820 1NEW YORKNo
3207RP1001XInternal MedicinePulmonary Disease177820 1NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
11410879MEDICAIDNEW YORK
2110101051OTHERNEW YORKRAILROAD MEDICARE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.